TNGX – tango therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tango Therapeutics (NASDAQ:TNGX) had its price target raised by analysts at Guggenheim from $12.00 to $18.00. They now have a "buy" rating on the stock.
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight [Yahoo! Finance]
Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor [Yahoo! Finance]
Form SCHEDULE 13D/A Tango Therapeutics, Inc. Filed by: Third Rock Ventures IV, L.P.
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: FARALLON PARTNERS L L C/CA
Form 4 Tango Therapeutics, Inc. For: Feb 02 Filed by: Beckman Daniella
Form 4 Tango Therapeutics, Inc. For: Feb 02 Filed by: Weber Barbara
Form 4 Tango Therapeutics, Inc. For: Feb 02 Filed by: Crystal Adam
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.